Fate Therapeutics Inc (FATE)
3.86
-0.01
(-0.26%)
USD |
NASDAQ |
Apr 26, 09:45
Fate Therapeutics Price: 3.86 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 4.14 | 4.15 | 3.78 | 3.87 | 3.601M |
| Apr 24, 2024 | 4.59 | 4.66 | 4.17 | 4.30 | 2.273M |
| Apr 23, 2024 | 4.79 | 5.02 | 4.485 | 4.54 | 4.022M |
| Apr 22, 2024 | 4.84 | 4.92 | 4.665 | 4.78 | 1.434M |
| Apr 19, 2024 | 4.95 | 5.11 | 4.695 | 4.79 | 2.692M |
| Apr 18, 2024 | 5.27 | 5.345 | 4.98 | 5.04 | 2.343M |
| Apr 17, 2024 | 5.50 | 5.63 | 5.21 | 5.27 | 2.149M |
| Apr 16, 2024 | 5.53 | 5.74 | 5.32 | 5.38 | 2.815M |
| Apr 15, 2024 | 5.80 | 5.955 | 5.39 | 5.64 | 2.687M |
| Apr 12, 2024 | 5.95 | 5.95 | 5.67 | 5.77 | 1.838M |
| Apr 11, 2024 | 6.33 | 6.37 | 5.90 | 5.95 | 1.866M |
| Apr 10, 2024 | 6.38 | 6.48 | 6.23 | 6.27 | 2.401M |
| Apr 09, 2024 | 6.69 | 6.81 | 6.54 | 6.76 | 1.625M |
| Apr 08, 2024 | 6.98 | 6.98 | 6.42 | 6.71 | 2.134M |
| Apr 05, 2024 | 6.90 | 7.14 | 6.803 | 6.92 | 1.183M |
| Apr 04, 2024 | 7.18 | 7.345 | 6.925 | 6.97 | 1.202M |
| Apr 03, 2024 | 6.78 | 7.29 | 6.65 | 7.01 | 2.643M |
| Apr 02, 2024 | 6.84 | 7.08 | 6.75 | 6.80 | 1.873M |
| Apr 01, 2024 | 7.33 | 7.33 | 6.89 | 7.08 | 1.856M |
| Mar 28, 2024 | 7.27 | 7.65 | 7.23 | 7.34 | 2.716M |
| Mar 27, 2024 | 6.97 | 7.37 | 6.77 | 7.34 | 2.111M |
| Mar 26, 2024 | 7.03 | 7.13 | 6.68 | 6.86 | 2.943M |
| Mar 25, 2024 | 6.58 | 7.01 | 6.54 | 6.87 | 1.987M |
| Mar 22, 2024 | 7.47 | 7.59 | 6.61 | 6.61 | 1.997M |
| Mar 21, 2024 | 7.51 | 7.698 | 7.19 | 7.43 | 1.992M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.65
Minimum
Oct 27 2023
117.40
Maximum
Jan 14 2021
32.54
Average
24.17
Median
Price Benchmarks
| Amicus Therapeutics Inc | 10.20 |
| Regeneron Pharmaceuticals Inc | 882.30 |
| Sarepta Therapeutics Inc | 127.15 |
| ADMA Biologics Inc | 6.44 |
| Ocular Therapeutix Inc | 4.135 |
Price Related Metrics
| PS Ratio | 5.979 |
| Price to Book Value | 1.040 |
| Earnings Yield | -42.49% |
| Market Cap | 383.06M |